After a long and often controversial battle for transparency, the European Medicines Agency will from today become the first regulator to publish clinical study reports in a step toward opening up clinical trial data.
Clinical trial transparency is the name of the game with a new site launched this week aimed at allowing everyone to “locate, match, and share all publicly accessible data and documents” around medicines studies.
Two clinicians have devised a new system to prevent clinical trial documents being secretly altered to make new drugs look more effective than they are by using a similar system as the digital currency of bitcoin.